Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

AORT

Artivion (AORT)

Artivion Inc
Da:
Ordina per:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:AORT
DataOraFonteTitoloSimboloCompagnia
12/03/202520:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AORTArtivion Inc
11/03/202521:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AORTArtivion Inc
04/03/202522:05PR Newswire (US)Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceNYSE:AORTArtivion Inc
28/02/202520:28Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:AORTArtivion Inc
24/02/202522:08Edgar (US Regulatory)Form 8-K - Current reportNYSE:AORTArtivion Inc
24/02/202522:05PR Newswire (US)Artivion Reports Fourth Quarter and Full Year 2024 Financial ResultsNYSE:AORTArtivion Inc
10/02/202522:10PR Newswire (US)Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial ResultsNYSE:AORTArtivion Inc
30/01/202516:16Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNYSE:AORTArtivion Inc
27/01/202514:00PR Newswire (US)Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual MeetingNYSE:AORTArtivion Inc
10/12/202421:45Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:AORTArtivion Inc
09/12/202414:00PR Newswire (US)Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid ProsthesisNYSE:AORTArtivion Inc
08/11/202421:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:AORTArtivion Inc
08/11/202420:17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:AORTArtivion Inc
07/11/202422:05PR Newswire (US)Artivion Reports Third Quarter 2024 Financial ResultsNYSE:AORTArtivion Inc
05/11/202422:15PR Newswire (US)Artivion to Participate in Upcoming Investor ConferencesNYSE:AORTArtivion Inc
24/10/202422:15PR Newswire (US)Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial ResultsNYSE:AORTArtivion Inc
10/10/202422:10PR Newswire (US)Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual MeetingNYSE:AORTArtivion Inc
08/08/202422:05PR Newswire (US)Artivion Reports Second Quarter 2024 Financial ResultsNYSE:AORTArtivion Inc
25/07/202422:10PR Newswire (US)Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial ResultsNYSE:AORTArtivion Inc
01/07/202422:05PR Newswire (US)Artivion Amends Agreements with EndospanNYSE:AORTArtivion Inc
30/05/202422:12Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:AORTArtivion Inc
06/05/202422:05PR Newswire (US)Artivion Reports First Quarter 2024 Financial ResultsNYSE:AORTArtivion Inc
29/04/202414:05PR Newswire (US)Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual MeetingNYSE:AORTArtivion Inc
22/04/202422:10PR Newswire (US)Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial ResultsNYSE:AORTArtivion Inc
01/04/202422:10PR Newswire (US)Artivion to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNYSE:AORTArtivion Inc
11/03/202422:45Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:AORTArtivion Inc
06/03/202422:10PR Newswire (US)Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceNYSE:AORTArtivion Inc
15/02/202422:05PR Newswire (US)Artivion Reports Fourth Quarter and Full Year 2023 Financial ResultsNYSE:AORTArtivion Inc
14/02/202412:18Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:AORTArtivion Inc
01/02/202422:10PR Newswire (US)Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial ResultsNYSE:AORTArtivion Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:AORT